Brown-Forman director granted 5,586 SARs
Brown-Forman director Marshall Farrer reported an amended Form 4 showing a grant of 5,586 Stock Appreciation Rights tied to Class B Common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Brown-Forman director Marshall Farrer reported an amended Form 4 showing a grant of 5,586 Stock Appreciation Rights tied to Class B Common stock. These rights have a conversion or exercise price of $31.15 per share, become exercisable on May 1, 2028, and expire on April 30, 2035. The amendment corrects the number of stock appreciation rights previously reported due to a clerical error and shows Farrer's direct derivative holdings at 5,586 rights following the transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Appreciation Right | 5,586 | $0.00 | $0.00 |
Footnotes (1)
- F1. Amended to correct the number of stock appreciation rights reported on Form 4 filed on July 25, 2025, due to a clerical error.
Key Figures
Key Terms
Stock Appreciation Right financial
conversion or exercise price financial
Class B Common financial
Form 4 regulatory
clerical error other
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Brown-Forman (BF) report for Marshall Farrer?
Why was Marshall Farrer's Brown-Forman Form 4 filing amended?
What are the key terms of Marshall Farrer's stock appreciation rights at Brown-Forman (BF)?
Does the Brown-Forman (BF) insider filing show any stock sales by Marshall Farrer?
How many stock appreciation rights does Marshall Farrer hold after this Brown-Forman transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.